Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

NCT00091234 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

279

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

DRUG: gemtuzumab ozogamicin

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]